Viewing data from:

ATOVAQUONE

ANDA

ATOVAQUONE | A214272 | PAI HOLDINGS LLC DBA PHARMACEUTICAL ASSOCIATES INC AND DBA PAI PHARMA

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: MEPRON(TE code: AB)

API Supply Chain11 active DMFs6 inactive

10 active API suppliers hold Drug Master Files for this ingredient.

ZYDUS LIFESCIENCES LTDATOVAQUONE USP

DMF 209082007

ALCHYMARS ICM SM PRIVATE LTDATOVAQUONE USP

DMF 220572008

MATRIX PHARMACORP PRIVATE LTDATOVAQUONE USP

DMF 221342008

HETERO DRUGS LTDATOVAQUONE (FORM-A)

DMF 244462010

SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTDATOVAQUONE

DMF 253052011

TARO PHARMACEUTICAL INDUSTRIES LTDATOVAQUONE USP, MICRONIZED

DMF 269062013

ALIVUS LIFE SCIENCES LTDATOVAQUONE USP (D144 PROCESS)

DMF 311422016

APITORIA PHARMA PRIVATE LTDATOVAQUONE USP

DMF 316752017

NURAY CHEMICALS PRIVATE LTDATOVAQUONE USP

DMF 363392021

HETERO DRUGS LTDATOVAQUONE (FORM-A), PROCESS II

DMF 409522024

IPCA LABORATORIES LTDATOVAQUONE USP

DMF 422012025

USV LTDInactiveATOVAQUONE USP

DMF 206722007

ZHEJIANG HISOAR PHARMACEUTICAL CO LTDInactiveAtovaquone

DMF 210012007

ROLABO OUTSOURCING SLInactiveATOVAQUONE USP

DMF 213602008

EXCELLA GMBHInactiveATOVAQUONE

DMF 214682008

USV PRIVATE LTDInactiveATOVAQUONE USP (FORM III)

DMF 235132010

USV PRIVATE LTDInactiveATOVAQUONE USP (FORM I)

DMF 235562010

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 750MG/5ML

0 patents0 exclusivities▴

SUSPENSION;ORAL | Approved: Oct 25, 2021

No patent or exclusivity listings for this strength.